Plazomicin Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Plazomicin is a parenterally administered, broad spectrum aminoglycoside antibiotic typically used for moderate-to-severe urinary tract infections or pyelonephritis.Plazomicin Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Plazomicin Nitroso Impurity 1 CAS NO:NA Chemically represented as (S)-4-amino-N-((1R,2S,3S,4R,5S)-5-amino-4-(((2S,3R)-3-amino-6-(((2-hydroxyethyl)amino)methyl)-3,4-dihydro-2H-pyran-2-yl)oxy)-2-(((2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methyl(nitroso)amino)tetrahydro-2H-pyran-2-yl)oxy)-3-hydroxycyclohexyl)-2-hydroxybutanamide. Synchemia is the leading manufacturing and exporter of Plazomicin Nitroso Impurity 1. We supply Plazomicin Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0141411 |
| CAS No | NA |
| Mol.F. | C10H13ClN2O : HCl |
| Mol.Wt. | 212.7 : 36.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141412 |
| CAS No | NA |
| Mol.F. | C10H12N2O |
| Mol.Wt. | 176.2 |
| INV STATUS | In Stock |
| CAT No | SRC-N0141413 |
| CAS No | 500545-48-2 |
| Mol.F. | C15H26ClN3O2 |
| Mol.Wt. | 315.8 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141414 |
| CAS No | NA |
| Mol.F. | C3H9N3O3S |
| Mol.Wt. | 167.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141415 |
| CAS No | NA |
| Mol.F. | C7H9N3O |
| Mol.Wt. | 151.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141416 |
| CAS No | NA |
| Mol.F. | C26H28Cl2N6O4 |
| Mol.Wt. | 559.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141417 |
| CAS No | NA |
| Mol.F. | C14H20N4O5 |
| Mol.Wt. | 324.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141418 |
| CAS No | NA |
| Mol.F. | C25H28Cl2N6O5 |
| Mol.Wt. | 563.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141419 |
| CAS No | NA |
| Mol.F. | C26H30Cl2N6O5 |
| Mol.Wt. | 577.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141420 |
| CAS No | NA |
| Mol.F. | C25H26Cl2N6O4 |
| Mol.Wt. | 545.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141421 |
| CAS No | NA |
| Mol.F. | C21H18Cl2N4O4 |
| Mol.Wt. | 461.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141422 |
| CAS No | NA |
| Mol.F. | C34H26N4O6 |
| Mol.Wt. | 586.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141424 |
| CAS No | NA |
| Mol.F. | C12H17N3O3 |
| Mol.Wt. | 251.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141425 |
| CAS No | NA |
| Mol.F. | C18H17N5O |
| Mol.Wt. | 319.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141423 |
| CAS No | NA |
| Mol.F. | C13H17N3O5 |
| Mol.Wt. | 295.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141426 |
| CAS No | NA |
| Mol.F. | C32H27N5O3 |
| Mol.Wt. | 529.6 |
| INV STATUS | CUSTOM SYNTHESIS |